Jordan Technology Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Technology Report.

Press releases published on July 16, 2026

an hour ago

Quantum Cyber Reports Approximately $2 Million of Purchase Orders for Quantum Drone Corporation

Indeterminate GlobeNewswire

an hour ago

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

Indeterminate GlobeNewswire

an hour ago

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Indeterminate GlobeNewswire

an hour ago

Banzai Appoints David Abrams, Wyatt Jozwowski to Lead CreateStudio Business

Indeterminate GlobeNewswire

an hour ago

Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio

Indeterminate GlobeNewswire

an hour ago

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

Indeterminate GlobeNewswire

an hour ago

ZenaTech Closes 25th Acquisition with Alberta, Canada-based Velocity Geomatics Inc. Expanding Drone as a Service into Environmental and Regulatory Services in the Oil and Gas Sector

Indeterminate GlobeNewswire

an hour ago

Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

Indeterminate GlobeNewswire

an hour ago

Resignation of Director

Indeterminate GlobeNewswire

an hour ago

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

Indeterminate GlobeNewswire

an hour ago

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Indeterminate GlobeNewswire

an hour ago

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

an hour ago

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

Indeterminate GlobeNewswire

an hour ago

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Remix Therapeutics to Present at AACR Drug Discovery and Development Conference

Indeterminate GlobeNewswire

an hour ago

Palomino Laboratories Announces Binding LOI to Acquire Vega Links Inc. to Create a Next-Generation AI Interconnect Company

Indeterminate GlobeNewswire

an hour ago

Aurora Mobile's EngageLab Partners with Mocasa: Building a Robust Security Foundation for Digital Credit with Advanced OTP Solutions

Indeterminate GlobeNewswire

an hour ago

Curative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology Platform

Indeterminate GlobeNewswire

an hour ago

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025

Indeterminate GlobeNewswire

2 hours ago

Diagonal Therapeutics Announces First Patient Dosed in Phase 1/2 DIAMOND Clinical Trial of DIAG723 for Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire